Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.

Researchers found new genetic variants driving chronic kidney disease, offering potential targets for future drugs or ...

Already approved to treat four rare diseases, AstraZeneca’s Ultomiris has shown its ability against another rare disorder, ...

April 21 (Reuters) - AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met the main goal of a late-stage ...

For many patients, dialysis is not just a treatment—it becomes a defining part of life. Hours spent connected to a machine, ...

A nurse practitioner-led clinic for chronic kidney disease improves clinical outcomes and increases the use of ...

The 9th Annual Patient Symposium offers educational seminars on dialysis, nutrition, mental health and treatment options, ...

Renin-independent aldosterone production is associated with rapid kidney function decline in adults with hypertension, according to new data.

Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...

Kidney disease can cause facial swelling, itchiness, and blisters. Symptoms can depend on the stage of kidney disease. Uremic leontiasis ossea is a rare and severe complication of advanced kidney ...